Richard Gregg Insider Trading $VTAE Vitae Pharmaceuticals, Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Richard Gregg.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard Gregg. Richard Gregg is Chief Science Officer in Vitae Pharmaceuticals, Inc ($VTAE) and Chief Scientific Officer in Vitae Pharmaceuticals, Inc ($VTAE).
Richard Gregg in Vitae Pharmaceuticals, Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard Gregg: Chief Scientific Officer, Chief Science Officer
Holdings: 228,274 shares
Latest Transaction: Oct 25 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Richard Gregg in Vitae Pharmaceuticals, Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | D | 8.78 | 16,500 | 144,870 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | D | 8.58 | 32,750 | 280,995 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | D | 8.28 | 21,250 | 175,950 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | D | 14.40 | 14,306 | 206,006 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | D | 7.13 | 21,647 | 154,343 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Sell | D | 21.00 | 228,274 | 4,793,754 | 228,274 | 456.5 K to 228.3 K (-50.00 %) |
| Oct 21 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | M | 14.40 | 6,944 | 99,994 | 14,306 | |
| Oct 21 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | M | 7.13 | 29,657 | 211,454 | 21,647 | |
| Oct 21 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | M | 3.91 | 87,301 | 341,347 | 0 | |
| Oct 21 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Buy | M | 14.40 | 6,944 | 99,994 | 228,274 | 221.3 K to 228.3 K (+3.14 %) |
| Oct 21 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Buy | M | 7.13 | 29,657 | 211,454 | 221,330 | 191.7 K to 221.3 K (+15.47 %) |
| Oct 21 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Buy | M | 3.91 | 87,301 | 341,347 | 191,673 | 104.4 K to 191.7 K (+83.64 %) |
| Aug 17 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | A | 8.79 | 16,500 | 145,035 | 16,500 | |
| Aug 17 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Grant | A | 6.11 | 2,100 | 12,831 | 104,372 | 102.3 K to 104.4 K (+2.05 %) |
| Feb 16 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Scientific Of ... | Option Exercise | A | 8.58 | 32,750 | 280,995 | 32,750 | |
| Nov 17 2015 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | M | 3.91 | 15,000 | 58,650 | 87,301 | |
| Nov 17 2015 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | M | 6.90 | 6,773 | 46,734 | 0 | |
| Nov 17 2015 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | M | 3.91 | 13,695 | 53,547 | 0 | |
| Nov 17 2015 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | M | 3.91 | 65,089 | 254,498 | 102,301 | |
| Nov 17 2015 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Buy | M | 3.91 | 15,000 | 58,650 | 100,557 | 85.6 K to 100.6 K (+17.53 %) |
| Nov 17 2015 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Buy | M | 6.90 | 6,773 | 46,734 | 85,557 | 78.8 K to 85.6 K (+8.60 %) |
| Nov 17 2015 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Buy | M | 3.91 | 13,695 | 53,547 | 78,784 | 65.1 K to 78.8 K (+21.04 %) |
| Nov 17 2015 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Buy | M | 3.91 | 65,089 | 254,498 | 65,089 | 0 to 65.1 K |
| Feb 18 2015 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | A | 14.40 | 21,250 | 306,000 | 21,250 |
Page: 1